1-11 of 11
Elizabeth O'Donnell
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Updated Results from CARTITUDE-1: Phase 1b/2Study of Ciltacabtagene Autoleucel, a B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy, in Patients With Relapsed/Refractory Multiple Myeloma

Thomas Martin, Saad Z. Usmani, Jesús G. Berdeja, Andrzej Jakubowiak, Mounzer Agha, Adam D Cohen, Parameswaran Hari, David Avigan, Abhinav Deol, Myo Htut, Alexander Lesokhin, Nikhil C. Munshi, Elizabeth O'Donnell, A. Keith Stewart, Jordan M. Schecter, Jenna D. Goldberg, Carolyn C. Jackson, Tzu-Min Yeh, Arnob Banerjee, Alicia Allred, Enrique Zudaire, William Deraedt, Deepu Madduri, Yunsi Olyslager, Changwei Zhou, Lida Pacaud, Yi Lin, Sundar Jagannath
Journal: Blood
Blood (2021) 138 (Supplement 1): 549.
https://doi.org/10.1182/blood-2021-146060
Published: 2021
Journal Articles

Real-World Observations and Practical Considerations of Subcutaneous Daratumumab Administration in Multiple Myeloma

E. Bridget Kim, Elizabeth O'Donnell, Andrew R. Branagan, Jill N. Burke, Cynthia C. Harrington, Emerentia Agyemang, Noopur S. Raje, Andrew J. Yee
Journal: Blood
Blood (2021) 138 (Supplement 1): 5018.
https://doi.org/10.1182/blood-2021-153751
Published: 2021
Journal Articles

Molecular Features and Clinical Outcomes of Extramedullary Plasmacytomas

Rie Nakamoto-Matsubara, Valentina Nardi, Cristina Panaroni, Keertik Fulzele, Tomoaki Mori, Rakesh Verma, Andrew J. Yee, Andrew R. Branagan, Elizabeth O'Donnell, Noopur S. Raje
Journal: Blood
Blood (2021) 138 (Supplement 1): 398.
https://doi.org/10.1182/blood-2021-152784
Published: 2021
Journal Articles

COVID-19 Vaccine Responsiveness in Patients with Multiple Myeloma and Waldenström Macroglobulinemia

Andrew R. Branagan, Matthew M Lei, Jenny S Maron, Andrew J Yee, Elizabeth O'Donnell, Jorge J. Castillo, Noopur S. Raje, Steven P Treon, Catherine A Flynn, Clifton C. Mo, Omar Nadeem, Paul G. Richardson, Cristina Panaroni, Kirsten Meid, Zachary S. Bernstein, Rebecca T. Lyons, Zachary R Hunter, Maria Luisa Guerrera, Marilyn T. Gammon, Kathleen J. Lively, Lisette Packer, Matthew Waterman, Raquel Gallagher, Boris Juleg, Galit Alter, Shayna Sarosiek
Journal: Blood
Blood (2021) 138 (Supplement 1): 3801.
https://doi.org/10.1182/blood-2021-154089
Published: 2021
Journal Articles

CARTITUDE-1: Phase 1b/2 Study of Ciltacabtagene Autoleucel, a B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy, in Relapsed/Refractory Multiple Myeloma

Deepu Madduri, MD, Jesus G. Berdeja, MD, Saad Z. Usmani, MDMBBS,MBA, Andrzej Jakubowiak, MD PhD, Mounzer Agha, MD, Adam D. Cohen, MD, A. Keith Stewart, MBChB, Parameswaran Hari, MD MRCP, Myo Htut, MD, Elizabeth O'Donnell, MD, Nikhil C. Munshi, MD, David E. Avigan, MD, Abhinav Deol, MD, Alexander M. Lesokhin, MD, Indrajeet Singh, PhD, Enrique Zudaire, PhD, Tzu-Min Yeh, Alicia J. Allred, PhD, Yunsi Olyslager, MSc, Arnob Banerjee, MD, Jenna D. Goldberg, MD, Jordan M. Schecter, MD, Carolyn C. Jackson, MD MPH, William Deraedt, MSc, Sen Hong Zhuang, MD PhD, Jeffrey R. Infante, MD, Dong Geng, PhD, Xiaoling Wu, PhD, Marlene J. Carrasco, MD PhD MPH, Muhammad Akram, MD, Farah Hossain, PharmD, Syed Rizvi, MD, Frank Fan, MD PhD, Sundar Jagannath, MD, Yi Lin, MD PhD, Thomas Martin, III, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 22–25.
https://doi.org/10.1182/blood-2020-136307
Published: 2020
Journal Articles

TAK-573, an Anti-CD38/Attenuated Ifnα Fusion Protein, Has Clinical Activity and Modulates the Ifnα Receptor (IFNAR) Pathway in Patients with Relapsed/Refractory Multiple Myeloma

Dan T. Vogl, MD, Jonathan L. Kaufman, MD, Sara A. Holstein, MDPhD, Omar Nadeem, MD, Elizabeth O'Donnell, MD, Kaveri Suryanarayan, MD, Sabrina Collins, Xavier Parot, MD, Maria Chaudhry, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-141219
Published: 2020
Journal Articles

Analysis of Hospitalization and Readmissions after CAR T Cell Therapy

Elizabeth O'Donnell, MD, Hao Deng, MD, Kyan Safavi, William Driscoll, MD, Milcho Nikolov, Andrew J Yee, MD, Noopur Raje, MD, Matthiew Frigault, MD MSc, Dusan Handiziar, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2301.
https://doi.org/10.1182/blood-2018-99-112254
Published: 2018
Journal Articles

Ibrutinib Is Highly Active As First Line Therapy in Symptomatic Waldenstrom's Macroglobulinemia

Steven P Treon, MDPhDFRCP, Joshua Gustine, Kirsten Meid, MPH, Toni Dubeau, NP, Patricia Severns, NP, Christopher Patterson, MAcc, Lian Xu, Guang Yang, PhD, Xia Liu, MD, Maria Demos, BS, Amanda Kofides, BS, Jiaji Chen, BS, Manit Munshi, MS, Nickolas Tsakmaklis, BA, Gloria Chan, MS, Andrew J Yee, MD, Noopur Raje, MD, Elizabeth O'Donnell, MD, Zachary Hunter, PhD, Jorge J. Castillo, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2767.
https://doi.org/10.1182/blood.V130.Suppl_1.2767.2767
Published: 2017
Journal Articles

Final Results of a Phase 2 Study of Modified Lenalidomide, Bortezomib, and Dexamethasone (RVD lite) in Transplant-Ineligible Multiple Myeloma

Elizabeth O'Donnell, MD, Jacob Laubach, MD, Andrew J Yee, MD, Tianqi Chen, Carol Ann Huff, MD, Frank G. Basile, MD, Philip Wade, MD, Claudia Paba-Prada, MD, Irene M. Ghobrial, MD, Robert Schlossman, MD, Jill Burke, Harrington Cynthia, Kathleen Lively, Hannah Lyons, Nikhil Munshi, MD, Lorenzo Trippa, PhD, Kenneth C Anderson, MD, Paul G Richardson, MD, Noopur Raje, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3126.
https://doi.org/10.1182/blood.V130.Suppl_1.3126.3126
Published: 2017
Journal Articles

Initial Results of a Phase 1/2a, Dose Escalation Study of PVX-410 Multi-Peptide Cancer Vaccine in Patients with Smoldering Multiple Myeloma (SMM)

Michael (Luhua) Wang, MD, Ajay K. Nooka, MD MPH, Andrew J. Yee, MD, Sheeba K. Thomas, MD, Elizabeth O'Donnell, MD, Jatin Shah, MD, Donna M. Weber, MD, Jonathan L. Kaufman, MD, Sagar Lonial, MD, David Avigan, MD, Noopur Raje, MD
Journal: Blood
Blood (2014) 124 (21): 4737.
https://doi.org/10.1182/blood.V124.21.4737.4737
Published: 2014
Journal Articles

A Phase II Study of Modified Lenalidomide, Bortezomib, and Dexamethasone (RVD lite) for Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma

Elizabeth O'Donnell, MD, Jacob P. Laubach, MD, Andrew J Yee, MD, Carol Ann Huff, MD, Frank Basile, MD, Philip M. Wade, MD, Claudia E. Paba-Prada, MD, Irene M. Ghobrial, MD, Robert L Schlossman, MD, Nicole Couture, RN, Lauren Doherty, Hannah Lyons, RN, Caroline English, Nikhil Munshi, Kenneth C. Anderson, Paul G. Richardson, MD, Noopur Raje, MD
Journal: Blood
Blood (2014) 124 (21): 3454.
https://doi.org/10.1182/blood.V124.21.3454.3454
Published: 2014